AusAm Biotechnologies Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From AusAm Biotechnologies Inc.
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Therapeutic Antibodies, features profiles of Acceptys Inc., KaloBios Inc. and Rinat Neuroscience Corp. Plus these Start-Ups Across Health Care: Atritech Inc, AusAm Biotechnologies Inc., Cenix BioScience GMBH and TransOral Pharmaceuticals Inc.
Three-year-old AusAm Biotechnologies is actively pursuing both diagnostics and therapeutics, with all novel technologies based on its founding scientists' observations about the kidney. In diagnostics, it recently received FDA clearance for a highly sensitive test that detects precursors to kidney disease. The test has potential to become a wide screen, particularly for at-risk diabetics. In therapeutics, it is developing a polysaccharide-based class of anti-viral attachment inhibitors, which have potential in treatment of infectious diseases like AIDs, encephalitis and small pox.
- In Vitro Diagnostics